Description
Zoltrate® (Zolpidem) – Trusted Relief for Short-Term Insomnia
Zoltrate is a fast-acting, non-benzodiazepine hypnotic medication containing Zolpidem, developed specifically for the short-term treatment of insomnia. It facilitates rapid sleep onset by enhancing the action of GABA at selective receptor sites in the brain, helping users fall asleep faster and enjoy uninterrupted, restorative sleep.
Therapeutic Class:
Non-benzodiazepine Hypnotics (Imidazopyridines)
Indications:
-
Short-term treatment of insomnia with sleep initiation difficulty
-
Situational or transient insomnia
-
Difficulty falling asleep at bedtime
Mechanism of Action:
Zoltrate selectively targets the omega-1 subtype of the GABA-A receptor complex, amplifying GABA’s inhibitory effects in the central nervous system. This targeted action induces sedation with minimal anxiolytic or muscle relaxant effects, reducing next-day hangover symptoms often seen with traditional sedatives.
Available Dosage Forms:
-
Immediate-Release Tablets: 5 mg, 10 mg
-
Extended-Release Tablets (CR): 6.25 mg, 12.5 mg
-
Sublingual Tablets (as regionally approved)
-
Oral Spray (availability may vary by market)
Common Side Effects:
-
Drowsiness or excessive sleepiness
-
Dizziness or lightheadedness
-
Headache
-
Upset stomach, nausea, or diarrhea
-
Unusual sleep behaviors (e.g., sleepwalking, sleep-eating, sleep-driving)*
*Seek immediate medical advice if unusual sleep behaviors occur.
Precautions & Warnings:
-
Sedative Effects: Avoid driving or using heavy machinery after use.
-
Dependence Risk: Use at the lowest effective dose for the shortest possible duration.
-
Complex Sleep Behavior: Discontinue if sleep-related behaviors are observed.
-
Alcohol Interaction: Strictly avoid alcohol during treatment.
-
Geriatric Caution: Start at lower doses due to increased sensitivity.
Contraindications:
-
Known hypersensitivity to Zolpidem or any excipients
-
Patients with a history of complex sleep behaviors after Zolpidem use
-
Severe liver dysfunction
-
Respiratory depression, obstructive sleep apnea, or myasthenia gravis
Storage Guidelines:
-
Store between 20°C to 25°C (68°F to 77°F)
-
Protect from light, moisture, and heat
-
Keep out of reach of children and those without a prescription
Note: Zoltrate® should only be used under the supervision of a licensed healthcare provider. Misuse or unsupervised use may lead to dependency, cognitive impairment, and complex behaviors during sleep. Never take more than the prescribed dose or share with others.


Reviews
There are no reviews yet.